PMCPA Case
| Case number | AUTH/3593/12/21 |
| Company | LEO Pharma UK (voluntary admission; payments made by Leo Pharma A/S) |
| Issue | Undeclared transfers of value for 2020 (five ToVs omitted from UK 2020 disclosure) |
| Recipients | 4 health professionals; 1 healthcare organisation (British Association of Dermatology) |
| Activities | Congress sponsorship (HCO); advisory board member payments (HCPs) |
| Payment dates | November 2020 (4/11/2020; 11/11/2020; 18/11/2020; 25/11/2020) |
| Amounts | £30,000 (HCO); £1,875; £930; £375; £1,350 (HCPs) |
| Root cause | Human error in global upload; Excel report remained in “pending remediation” due to lack of oversight |
| Corrective actions | Updated and re-submitted 2020 disclosure; system upgrade; re-training; new cross-border engagement system to enable affiliate cross-checking |
| Applicable Code | 2019 |
| Breach clauses | Clause 24.1 |
| Complaint received | 17 December 2021 |
| Case completed | 17 October 2022 |
| Appeal | No appeal |
| Sanctions | Undertaking received; additional sanctions: Not stated |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.